Gladstone in the News
January 10, 2022
ABC News—COVID-19 vaccine maker Moderna recently announced that individuals might need a fourth shot to stay safe in the ongoing pandemic. Gladstone virologist Warner Greene argues that an additional dose of the available vaccine may not be ideal, and that future boosters should be designed to specifically protect against emerging strains of the virus.
Gladstone Experts
COVID-19
Virology
Greene Lab
Video
December 22, 2021
Check out our 2021 Year in Review video to learn what we were up to this past year
Communications
History
Article
December 22, 2021
Tristan Telson, a veteran in Gladstone's IT Department, talks about the favorite parts of his job, who has influenced his career, and what he likes to do in his free time
Information Technology
Profile
Article
December 20, 2021
Nearly 1,000 masks went to unhoused people and evacuees of Sierra Nevada fires
Institutional News
Pico
Gladstone in the News
December 15, 2021
The Conversation—Individuals who survive traumatic brain injury can suffer from life-long complications, such as cognitive deficits, seizures, and sleep disruption. Jeanne Paz, PhD, describes her work in mice showing that treatment with an antibody that blocks an element of immune system activation may be able to prevent such consequences.
Gladstone Experts
Traumatic Brain Injury
Neurological Disease
Paz Lab
Gladstone in the News
December 15, 2021
abc7 NEWS—Senior Investigator Leor Weinberger, PhD, and Research Investigator Sonali Chaturvedi, PhD, explain their work on a therapy that sharply reduces viral load in the nose of hamsters after a single administration and could add a promising new tool to the therapeutic arsenal against COVID-19.
Gladstone Experts
COVID-19
Virology
Weinberger Lab
Gladstone in the News
December 14, 2021
San Francisco Business Times—Senior Investigator Leor Weinberger, PhD, pioneered a new class of antivirals called therapeutic interfering particles (TIPs), which were recently shown to be effective against SARS-CoV-2 in animal models. The approach is now being developed by a startup company and will be headed to clinical trials.
Gladstone Experts
COVID-19
Center for Cell Circuitry
Virology
Weinberger Lab
Gladstone in the News
December 14, 2021
San Francisco Chronicle—The omicron variant of SARS-CoV-2 is spreading rapidly, but it may not be a reason for panic. Nadia Roan explains that our immune system’s cellular response to the vaccines should hold up well against the omicron variant. In addition, Warner Greene predicts that if the variant spreads rapidly but causes just mild disease, it might actually help establish immunity globally, protecting people in places where vaccine access has been limited.
Gladstone Experts
COVID-19
Greene Lab
Roan Lab
Video
December 13, 2021
Learn how to define your personal brand
Communications
Video
December 10, 2021
A pioneer of HIV research discusses the last 40 years of HIV/AIDS research and what’s next
HIV/AIDS
Greene Lab
